Consequently, the ErbB receptor-mediated cytosolic phosphorylation activity is a reporter for the induction of malignant transformation in breast epithelium, and blocking ErbB activity acts supportive in breast cancer chemotherapy [8]. Here, EGFR is linked to breast cancer.